Search Results - April Killikelly
- Showing 1 - 6 results of 6
-
1
-
2
-
3
-
4
-
5
Cost-effectiveness of RSVpreF vaccine and nirsevimab for the prevention of respiratory syncytial virus disease in Canadian infants by Gebremedhin Beedemariam Gebretekle, Man Wah Yeung, Raphael Ximenes, Alexandra Cernat, Alison E. Simmons, April Killikelly, Winnie Siu, Ellen Rafferty, Nicholas Brousseau, Matthew Tunis, Ashleigh R. Tuite
Published 2024Artigo -
6
Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera by Joan O. Ngwuta, Man Chen, Kayvon Modjarrad, Michael Joyce, Masaru Kanekiyo, Azad Kumar, Hadi M. Yassine, Syed M. Moin, April Killikelly, Gwo‐Yu Chuang, Aliaksandr Druz, Ivelin S. Georgiev, Emily J. Rundlet, Mallika Sastry, Guillaume B. E. Stewart-Jones, Yongping Yang, Baoshan Zhang, Martha Nason, Cristina Capella, Mark E. Peeples, Julie E. Ledgerwood, Jason S. McLellan, Peter D. Kwong, Barney S. Graham
Published 2015Artigo
Search Tools:
Related Subjects
Medicine
Immunology
Virology
Biology
Internal medicine
Antigen
Disease
Glycoprotein
Immunogenicity
Intensive care medicine
Molecular biology
Respiratory system
Virus
Anatomy
Antibody
Antigenicity
Biochemistry
Calnexin
Calreticulin
Case fatality rate
Cell biology
Chaperone (clinical)
Chemistry
Cost effectiveness
Cyclophilin
Disease prevention
Economic growth
Economics
Emergency medicine
Endoplasmic reticulum